{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:16:21Z","timestamp":1789042581424,"version":"build-2803163510"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Bourse du Fonds d\u2019enseignement et de Recherche (FER) de la Facult\u00e9 de Pharmacie de l\u2019Universit\u00e9 Laval"},{"name":"International Essential Tremor Foundation, United States"},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["253895"],"award-info":[{"award-number":["253895"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Association des personnes concern\u00e9es par le tremblement essentiel"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-024-01736-4","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T04:02:22Z","timestamp":1725076942000},"page":"2341-2359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Postmortem Fatty Acid Abnormalities in the Cerebellum of Patients with Essential Tremor"],"prefix":"10.1007","volume":"23","author":[{"given":"M\u00e9lissa","family":"Simard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koralie","family":"M\u00e9lan\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Berthiaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyntia","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pshevorskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Julien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H.","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Calon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,31]]},"reference":[{"key":"1736_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.5334\/tohm.198","volume":"4","author":"ED Louis","year":"2014","unstructured":"Louis ED, Ottman R. How many people in the USA have essential tremor? Deriving a population estimate based on epidemiological data. Tremor Other Hyperkinet Mov (N Y). 2014;4:259.","journal-title":"Tremor Other Hyperkinet Mov (NY)"},{"key":"1736_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5334\/tohm.632","volume":"11","author":"ED Louis","year":"2021","unstructured":"Louis ED, McCreary M. How common is essential Tremor? Update on the Worldwide Prevalence of essential tremor. Tremor Other Hyperkinet Mov (N Y). 2021;11:28.","journal-title":"Tremor Other Hyperkinet Mov (NY)"},{"issue":"6","key":"1736_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1586\/ern.12.49","volume":"12","author":"MA Thenganatt","year":"2012","unstructured":"Thenganatt MA, Louis ED. Distinguishing essential tremor from Parkinson\u2019s disease: bedside tests and laboratory evaluations. Expert Rev Neurother. 2012;12(6):687\u201396.","journal-title":"Expert Rev Neurother"},{"key":"1736_CR4","doi-asserted-by":"crossref","unstructured":"Louis ED, Faust PL. Essential tremor pathology: neurodegeneration and reorganization of neuronal connections. Nat Rev Neurol. 2020.","DOI":"10.1038\/s41582-019-0302-1"},{"issue":"12","key":"1736_CR5","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1093\/brain\/awm266","volume":"130","author":"ED Louis","year":"2007","unstructured":"Louis ED, Faust PL, Vonsattel JPG, Honig LS, Rajput A, Robinson CA, et al. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain. 2007;130(12):3297\u2013307.","journal-title":"Brain"},{"issue":"3","key":"1736_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00401-022-02535-z","volume":"145","author":"ED Louis","year":"2023","unstructured":"Louis ED, Martuscello RT, Gionco JT, Hartstone WG, Musacchio JB, Portenti M, et al. Histopathology of the cerebellar cortex in essential tremor and other neurodegenerative motor disorders: comparative analysis of 320 brains. Acta Neuropathol. 2023;145(3):265\u201383.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1736_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-021-00314-w","volume":"7","author":"T Welton","year":"2021","unstructured":"Welton T, Cardoso F, Carr JA, Chan LL, Deuschl G, Jankovic J, et al. Essential tremor. Nat Rev Dis Primers. 2021;7(1):83.","journal-title":"Nat Rev Dis Primers"},{"key":"1736_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fendo.2017.00060","volume":"8","author":"KD Bruce","year":"2017","unstructured":"Bruce KD, Zsombok A, Eckel RH. Lipid Processing in the brain: a Key Regulator of systemic metabolism. Front Endocrinol (Lausanne). 2017;8:60.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1736_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cnd.2014.03.003","volume":"49","author":"F Calon","year":"2014","unstructured":"Calon F. Modulation des lipides du cerveau par l\u2019alimentation: \u00e9tudes chez des mod\u00e8les animaux de maladies neurod\u00e9g\u00e9n\u00e9ratives. Cahiers De Nutr et de Di\u00e9t\u00e9tique. 2014;49(3):120\u20135.","journal-title":"Cahiers De Nutr et de Di\u00e9t\u00e9tique"},{"issue":"2","key":"1736_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1471-4159.1990.tb01889.x","volume":"54","author":"M S\u00f6derberg","year":"1990","unstructured":"S\u00f6derberg M, Edlund C, Kristensson K, Dallner G. Lipid compositions of different regions of the human brain during aging. J Neurochem. 1990;54(2):415\u201323.","journal-title":"J Neurochem"},{"issue":"7","key":"1736_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.neuint.2009.04.018","volume":"55","author":"M Ouellet","year":"2009","unstructured":"Ouellet M, Emond V, Chen CT, Julien C, Bourasset F, Oddo S, et al. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study. Neurochem Int. 2009;55(7):476\u201382.","journal-title":"Neurochem Int"},{"issue":"4","key":"1736_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.stem.2015.08.001","volume":"17","author":"LK Hamilton","year":"2015","unstructured":"Hamilton LK, Dufresne M, Jopp\u00e9 SE, Petryszyn S, Aumont A, Calon F, et al. Aberrant lipid metabolism in the Forebrain Niche suppresses adult neural stem cell proliferation in an animal model of Alzheimer\u2019s Disease. Cell Stem Cell. 2015;17(4):397\u2013411.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"1736_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2174\/156720511796391881","volume":"8","author":"F Calon","year":"2011","unstructured":"Calon F. Omega-3 polyunsaturated fatty acids in Alzheimer\u2019s disease: key questions and partial answers. Curr Alzheimer Res. 2011;8(5):470\u20138.","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"1736_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1471-4159.2012.07772.x","volume":"122","author":"D Arsenault","year":"2012","unstructured":"Arsenault D, Julien C, Chen CT, Bazinet RP, Calon F. Dietary intake of unsaturated fatty acids modulates physiological properties of entorhinal cortex neurons in mice. J Neurochem. 2012;122(2):427\u201343.","journal-title":"J Neurochem"},{"issue":"1","key":"1736_CR15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuroscience.2008.12.006","volume":"159","author":"A Phivilay","year":"2009","unstructured":"Phivilay A, Julien C, Tremblay C, Berthiaume L, Julien P, Gigu\u00e8re Y, et al. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer\u2019s disease. Neuroscience. 2009;159(1):296\u2013307.","journal-title":"Neuroscience"},{"issue":"5","key":"1736_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1023\/A:1022478503367","volume":"23","author":"RJ Kaplan","year":"1998","unstructured":"Kaplan RJ, Greenwood CE. Dietary saturated fatty acids and brain function. Neurochem Res. 1998;23(5):615\u201326.","journal-title":"Neurochem Res"},{"issue":"12","key":"1736_CR17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrn3820","volume":"15","author":"RP Bazinet","year":"2014","unstructured":"Bazinet RP, Laye S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci. 2014;15(12):771\u201385.","journal-title":"Nat Rev Neurosci"},{"key":"1736_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.plefa.2014.10.003","volume":"92","author":"N Salem","year":"2015","unstructured":"Salem N, Vandal M, Calon F. The benefit of docosahexaenoic acid for the adult brain in aging and dementia. Prostaglandins Leukot Essent Fat Acids. 2015;92:15\u201322.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"1\u20132","key":"1736_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plefa.2014.05.001","volume":"91","author":"C Joffre","year":"2014","unstructured":"Joffre C, Nadjar A, Lebbadi M, Calon F, Laye S. n-3 LCPUFA improves cognition: the young, the old and the sick. Prostaglandins Leukot Essent Fat Acids. 2014;91(1\u20132):1\u201320.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"5","key":"1736_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.neuint.2005.12.002","volume":"48","author":"C Julien","year":"2006","unstructured":"Julien C, Berthiaume L, Hadj-Tahar A, Rajput AH, Bedard PJ, Di Paolo T, et al. Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys. Neurochem Int. 2006;48(5):404\u201314.","journal-title":"Neurochem Int"},{"issue":"4","key":"1736_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.arr.2011.03.001","volume":"10","author":"M Bousquet","year":"2011","unstructured":"Bousquet M, Calon F, Cicchetti F. Impact of \u03c9-3 fatty acids in Parkinson\u2019s disease. Ageing Res Rev. 2011;10(4):453\u201363.","journal-title":"Ageing Res Rev"},{"key":"1736_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.nbd.2018.10.001","volume":"121","author":"S Hernando","year":"2019","unstructured":"Hernando S, Requejo C, Herran E, Ruiz-Ortega JA, Morera-Herreras T, Lafuente JV, et al. Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson\u2019s disease: the role of glia and NRf2 regulation. Neurobiol Dis. 2019;121:252\u201362.","journal-title":"Neurobiol Dis"},{"key":"1736_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0090-6980(02)00031-X","volume":"68\u201369","author":"NG Bazan","year":"2002","unstructured":"Bazan NG, Colangelo V, Lukiw WJ. Prostaglandins and other lipid mediators in Alzheimer\u2019s disease. Prostaglandins Other Lipid Mediat. 2002;68\u201369:197\u2013210.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"9","key":"1736_CR24","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1073\/pnas.0837397100","volume":"100","author":"P Teismann","year":"2003","unstructured":"Teismann P, Tieu K, Choi DK, Wu DC, Naini A, Hunot S, et al. Cyclooxygenase-2 is instrumental in Parkinson\u2019s disease neurodegeneration. Proc Natl Acad Sci USA. 2003;100(9):5473\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1736_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.tifs.2017.09.003","volume":"69","author":"O Kerdiles","year":"2017","unstructured":"Kerdiles O, Lay\u00e9 S, Calon F. Omega-3 polyunsaturated fatty acids and brain health: preclinical evidence for the prevention of neurodegenerative diseases. Trends Food Sci Technol. 2017;69:203\u201313.","journal-title":"Trends Food Sci Technol"},{"issue":"5","key":"1736_CR26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.neuron.2004.08.013","volume":"43","author":"F Calon","year":"2004","unstructured":"Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer\u2019s disease mouse model. Neuron. 2004;43(5):633\u201345.","journal-title":"Neuron"},{"issue":"2","key":"1736_CR27","doi-asserted-by":"publisher","first-page":"e17397","DOI":"10.1371\/journal.pone.0017397","volume":"6","author":"D Arsenault","year":"2011","unstructured":"Arsenault D, Julien C, Tremblay C, Calon F. DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PLoS ONE. 2011;6(2):e17397.","journal-title":"PLoS ONE"},{"issue":"3","key":"1736_CR28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1460-9568.2005.04253.x","volume":"22","author":"F Calon","year":"2005","unstructured":"Calon F, Lim GP, Morihara T, Yang F, Ubeda O, Salem N, et al. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer\u2019s disease. Eur J Neurosci. 2005;22(3):617\u201326.","journal-title":"Eur J Neurosci"},{"issue":"24","key":"1736_CR29","doi-asserted-by":"publisher","first-page":"9173","DOI":"10.1523\/JNEUROSCI.1000-15.2015","volume":"35","author":"BT Casali","year":"2015","unstructured":"Casali BT, Corona AW, Mariani MM, Karlo JC, Ghosal K, Landreth GE. Omega-3 fatty acids augment the actions of Nuclear receptor agonists in a mouse model of Alzheimer\u2019s Disease. J Neurosci. 2015;35(24):9173\u201381.","journal-title":"J Neurosci"},{"issue":"3","key":"1736_CR30","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nbd.2008.12.002","volume":"33","author":"CR Hooijmans","year":"2009","unstructured":"Hooijmans CR, Van der Zee CE, Dederen PJ, Brouwer KM, Reijmer YD, van Groen T, et al. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe\/PS1dE9 mice. Neurobiol Dis. 2009;33(3):482\u201398.","journal-title":"Neurobiol Dis"},{"issue":"12","key":"1736_CR31","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1523\/JNEUROSCI.4225-04.2005","volume":"25","author":"GP Lim","year":"2005","unstructured":"Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci. 2005;25(12):3032\u201340.","journal-title":"J Neurosci"},{"issue":"5","key":"1736_CR32","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/jnr.22266","volume":"88","author":"SE Perez","year":"2010","unstructured":"Perez SE, Berg BM, Moore KA, He B, Counts SE, Fritz JJ, et al. DHA diet reduces AD pathology in young APPswe\/PS1 Delta E9 transgenic mice: possible gender effects. J Neurosci Res. 2010;88(5):1026\u201340.","journal-title":"J Neurosci Res"},{"issue":"5","key":"1736_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.plipres.2009.04.001","volume":"48","author":"SC Cunnane","year":"2009","unstructured":"Cunnane SC, Plourde M, Pifferi F, B\u00e9gin M, F\u00e9art C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer\u2019s disease. Prog Lipid Res. 2009;48(5):239\u201356.","journal-title":"Prog Lipid Res"},{"issue":"3","key":"1736_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11064-009-0087-5","volume":"35","author":"T Fraser","year":"2010","unstructured":"Fraser T, Tayler H, Love S. Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer\u2019s disease. Neurochem Res. 2010;35(3):503\u201313.","journal-title":"Neurochem Res"},{"issue":"3","key":"1736_CR35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3233\/JAD-2012-110629","volume":"29","author":"SC Cunnane","year":"2012","unstructured":"Cunnane SC, Schneider JA, Tangney C, Tremblay-Mercier J, Fortier M, Bennett DA, et al. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis. 2012;29(3):691\u20137.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1736_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/NEN.0b013e3181922348","volume":"68","author":"C Julien","year":"2009","unstructured":"Julien C, Tremblay C, \u00c9mond V, Lebbadi M, Salem N, Bennett DA, et al. Sirtuin 1 reduction parallels the Accumulation of tau in Alzheimer Disease. J Neuropathology Experimental Neurol. 2009;68(1):48\u201358.","journal-title":"J Neuropathology Experimental Neurol"},{"issue":"1","key":"1736_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.plefa.2012.04.006","volume":"88","author":"SC Cunnane","year":"2013","unstructured":"Cunnane SC, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P. Docosahexaenoic acid homeostasis, brain aging and Alzheimer\u2019s disease: can we reconcile the evidence? Prostaglandins Leukot Essent Fat Acids. 2013;88(1):61\u201370.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"4","key":"1736_CR38","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1096\/fj.07-9677com","volume":"22","author":"M Bousquet","year":"2008","unstructured":"Bousquet M, Saint-Pierre M, Julien C, Salem N, Cicchetti F, Calon F. Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson\u2019s disease. FASEB J. 2008;22(4):1213\u201325.","journal-title":"FASEB J"},{"issue":"8","key":"1736_CR39","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.pnpbp.2009.07.018","volume":"33","author":"M Bousquet","year":"2009","unstructured":"Bousquet M, Gibrat C, Saint-Pierre M, Julien C, Calon F, Cicchetti F. Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1401\u20138.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1736_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2217\/17460875.3.2.133","volume":"3","author":"F Calon","year":"2008","unstructured":"Calon F, Cicchetti F. Can we prevent Parkinson\u2019s disease with n-3 polyunsaturated fatty acids? Future Lipidol - FUTURE LIPIDOL. 2008;3:133\u20137.","journal-title":"Future Lipidol - FUTURE LIPIDOL"},{"key":"1736_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jnutbio.2015.11.014","volume":"30","author":"K Coulombe","year":"2016","unstructured":"Coulombe K, Saint-Pierre M, Cisbani G, St-Amour I, Gibrat C, Gigu\u00e8re-Rancourt A, et al. Partial neurorescue effects of DHA following a 6-OHDA lesion of the mouse dopaminergic system. J Nutr Biochem. 2016;30:133\u201342.","journal-title":"J Nutr Biochem"},{"key":"1736_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/B978-0-444-64189-2.00016-0","volume":"155","author":"ED Louis","year":"2018","unstructured":"Louis ED. Essential tremor and the cerebellum. Handb Clin Neurol. 2018;155:245\u201358.","journal-title":"Handb Clin Neurol"},{"key":"1736_CR43","doi-asserted-by":"crossref","unstructured":"Louis ED, Huang, CC, Dyke JP, Long Z, Dydak U. Neuroimaging studies of essential tremor: how well do these studies support\/refute the neurodegenerative hypothesis? Tremor Other Hyperkinet Mov (N Y). 2014;4(235).","DOI":"10.5334\/tohm.224"},{"issue":"Pt 10","key":"1736_CR44","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1093\/brain\/awt238","volume":"136","author":"R Babij","year":"2013","unstructured":"Babij R, Lee M, Cort\u00e9s E, Vonsattel JP, Faust PL, Louis ED. Purkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains. Brain. 2013;136(Pt 10):3051\u201361.","journal-title":"Brain"},{"issue":"Pt 1","key":"1736_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/brain\/awr301","volume":"135","author":"S Paris-Robidas","year":"2012","unstructured":"Paris-Robidas S, Brochu E, Sintes M, Emond V, Bousquet M, Vandal M, et al. Defective dentate nucleus GABA receptors in essential tremor. Brain. 2012;135(Pt 1):105\u201316.","journal-title":"Brain"},{"key":"1736_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.nbd.2015.07.016","volume":"82","author":"E B\u00e9liveau","year":"2015","unstructured":"B\u00e9liveau E, Tremblay C, Aubry-Lafontaine \u00c9, Paris-Robidas S, Delay C, Robinson C, et al. Accumulation of amyloid-\u03b2 in the cerebellar cortex of essential tremor patients. Neurobiol Dis. 2015;82:397\u2013408.","journal-title":"Neurobiol Dis"},{"issue":"27","key":"1736_CR47","doi-asserted-by":"publisher","first-page":"13592","DOI":"10.1073\/pnas.1817689116","volume":"116","author":"X Zhang","year":"2019","unstructured":"Zhang X, Santaniello S. Role of cerebellar GABAergic dysfunctions in the origins of essential tremor. Proc Natl Acad Sci U S A. 2019;116(27):13592\u2013601.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1736_CR48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00401-023-02602-z","volume":"146","author":"RT Martuscello","year":"2023","unstructured":"Martuscello RT, Chen ML, Reiken S, Sittenfeld LR, Ruff DS, Ni CL, et al. Defective cerebellar ryanodine receptor type 1 and endoplasmic reticulum calcium \u2018leak\u2019 in tremor pathophysiology. Acta Neuropathol. 2023;146(2):301\u201318.","journal-title":"Acta Neuropathol"},{"issue":"13","key":"1736_CR49","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/mds.25819","volume":"29","author":"C Delay","year":"2014","unstructured":"Delay C, Tremblay C, Brochu E, Paris-Robidas S, Emond V, Rajput AH, et al. Increased LINGO1 in the cerebellum of essential tremor patients. Mov Disord. 2014;29(13):1637\u201347.","journal-title":"Mov Disord"},{"issue":"6","key":"1736_CR50","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00401-013-1108-7","volume":"125","author":"SH Kuo","year":"2013","unstructured":"Kuo SH, Tang G, Louis ED, Ma K, Babji R, Balatbat M, et al. Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau. Acta Neuropathol. 2013;125(6):879\u201389.","journal-title":"Acta Neuropathol"},{"issue":"16 Pt 2","key":"1736_CR51","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1212\/01.wnl.0000310425.76205.02","volume":"70","author":"HA Shill","year":"2008","unstructured":"Shill HA, Adler CH, Sabbagh MN, Connor DJ, Caviness JN, Hentz JG, et al. Pathologic findings in prospectively ascertained essential tremor subjects. Neurology. 2008;70(16 Pt 2):1452\u20135.","journal-title":"Neurology"},{"issue":"5","key":"1736_CR52","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.parkreldis.2012.01.013","volume":"18","author":"AH Rajput","year":"2012","unstructured":"Rajput AH, Robinson CA, Rajput ML, Robinson SL, Rajput A. Essential tremor is not dependent upon cerebellar Purkinje cell loss. Parkinsonism Relat Disord. 2012;18(5):626\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"1736_CR53","first-page":"262","volume":"462","author":"MF Ibrahim","year":"2021","unstructured":"Ibrahim MF, Beevis JC, Empson RM, Essential. Tremor - Cerebellar Driven Disorder? Neurosci. 2021;462:262\u201373.","journal-title":"Tremor - Cerebellar Driven Disorder? Neurosci"},{"key":"1736_CR54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/0163-7827(81)90094-1","volume":"20","author":"J Lieb","year":"1981","unstructured":"Lieb J, Horrobin DF. Treatment of lithium-induced tremor and familial essential tremor with essential fatty acids. Prog Lipid Res. 1981;20:535\u20137.","journal-title":"Prog Lipid Res"},{"issue":"4","key":"1736_CR55","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1172\/JCI83621","volume":"126","author":"B Voller","year":"2016","unstructured":"Voller B, Lines E, McCrossin G, Tinaz S, Lungu C, Grimes G, et al. Dose-escalation study of octanoic acid in patients with essential tremor. J Clin Invest. 2016;126(4):1451\u20137.","journal-title":"J Clin Invest"},{"issue":"3\u20134","key":"1736_CR56","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000111579","volume":"29","author":"N Scarmeas","year":"2007","unstructured":"Scarmeas N, Louis ED. Mediterranean diet and essential tremor. A case-control study. Neuroepidemiology. 2007;29(3\u20134):170\u20137.","journal-title":"Neuroepidemiology"},{"issue":"5","key":"1736_CR57","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S0022-2275(20)42702-6","volume":"9","author":"L Svennerholm","year":"1968","unstructured":"Svennerholm L. Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res. 1968;9(5):570\u20139.","journal-title":"J Lipid Res"},{"issue":"6","key":"1736_CR58","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1046\/j.1471-4159.1998.71062528.x","volume":"71","author":"M Mart\u00ednez","year":"1998","unstructured":"Mart\u00ednez M, Mougan I. Fatty acid composition of human brain phospholipids during normal development. J Neurochem. 1998;71(6):2528\u201333.","journal-title":"J Neurochem"},{"issue":"6","key":"1736_CR59","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1212\/01.WNL.0000115145.18830.1A","volume":"62","author":"A Rajput","year":"2004","unstructured":"Rajput A, Robinson CA, Rajput AH. Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology. 2004;62(6):932\u20136.","journal-title":"Neurology"},{"issue":"10","key":"1736_CR60","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1002\/jnr.21667","volume":"86","author":"C Julien","year":"2008","unstructured":"Julien C, Tremblay C, Bendjelloul F, Phivilay A, Coulombe MA, Emond V, et al. Decreased drebrin mRNA expression in Alzheimer disease: correlation with tau pathology. J Neurosci Res. 2008;86(10):2292\u2013302.","journal-title":"J Neurosci Res"},{"issue":"1","key":"1736_CR61","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/NEN.0b013e3181922348","volume":"68","author":"C Julien","year":"2009","unstructured":"Julien C, Tremblay C, Emond V, Lebbadi M, Salem N, Bennett DA, et al. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol. 2009;68(1):48\u201358.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"1736_CR62","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/01.RES.49.2.316","volume":"49","author":"NA Shaikh","year":"1981","unstructured":"Shaikh NA, Downar E. Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis. Circ Res. 1981;49(2):316\u201325.","journal-title":"Circ Res"},{"key":"1736_CR63","volume-title":"Extraction, purification, and analysis of lipids from animal tissues","author":"NA Shaikh","year":"1986","unstructured":"Shaikh NA. Extraction, purification, and analysis of lipids from animal tissues. New York: Raven; 1986."},{"issue":"1","key":"1736_CR64","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0022-2275(20)38861-1","volume":"27","author":"G Lepage","year":"1986","unstructured":"Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986;27(1):114\u201320.","journal-title":"J Lipid Res"},{"issue":"9","key":"1736_CR65","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11745-015-4055-3","volume":"50","author":"MS Da Silva","year":"2015","unstructured":"Da Silva MS, Julien P, P\u00e9russe L, Vohl MC, Rudkowska I. Natural rumen-derived trans fatty acids are Associated with metabolic markers of Cardiac Health. Lipids. 2015;50(9):873\u201382.","journal-title":"Lipids"},{"issue":"9","key":"1736_CR66","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1097\/NEN.0b013e31822c62cf","volume":"70","author":"C Tremblay","year":"2011","unstructured":"Tremblay C, St-Amour I, Schneider J, Bennett DA, Calon F. Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol. 2011;70(9):788\u201398.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1736_CR67","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12035-014-8662-4","volume":"50","author":"GY Sun","year":"2014","unstructured":"Sun GY, Chuang DY, Zong Y, Jiang J, Lee JC, Gu Z, et al. Role of cytosolic phospholipase A2 in oxidative and inflammatory signaling pathways in different cell types in the central nervous system. Mol Neurobiol. 2014;50(1):6\u201314.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1736_CR68","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1194\/jlr.M200298-JLR200","volume":"44","author":"TA Rosenberger","year":"2003","unstructured":"Rosenberger TA, Villacreses NE, Contreras MA, Bonventre JV, Rapoport SI. Brain lipid metabolism in the cPLA2 knockout mouse. J Lipid Res. 2003;44(1):109\u201317.","journal-title":"J Lipid Res"},{"issue":"3","key":"1736_CR69","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/1073858405285923","volume":"12","author":"AA Farooqui","year":"2006","unstructured":"Farooqui AA, Horrocks LA. Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly. Neuroscientist. 2006;12(3):245\u201360.","journal-title":"Neuroscientist"},{"issue":"3","key":"1736_CR70","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1124\/pr.58.3.7","volume":"58","author":"AA Farooqui","year":"2006","unstructured":"Farooqui AA, Ong WY, Horrocks LA. Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev. 2006;58(3):591\u2013620.","journal-title":"Pharmacol Rev"},{"issue":"8","key":"1736_CR71","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/0006-3223(91)90235-E","volume":"30","author":"DF Horrobin","year":"1991","unstructured":"Horrobin DF, Manku MS, Hillman H, Iain A, Glen M. Fatty acid levels in the brains of schizophrenics and normal controls. Biol Psychiatry. 1991;30(8):795\u2013805.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"1736_CR72","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/mds.870130510","volume":"13","author":"K Eder","year":"1998","unstructured":"Eder K, Kish SJ, Kirchgessner M, Ross BM. Brain phospholipids and fatty acids in Friedreich\u2019s ataxia and spinocerebellar atrophy type-1. Mov Disord. 1998;13(5):813\u20139.","journal-title":"Mov Disord"},{"key":"1736_CR73","unstructured":"Jeon K. International Review of Cell and Molecular Biology. Academic; 2016. p. 368."},{"issue":"7","key":"1736_CR74","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1194\/jlr.R700020-JLR200","volume":"49","author":"JE Vance","year":"2008","unstructured":"Vance JE. Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids. J Lipid Res. 2008;49(7):1377\u201387.","journal-title":"J Lipid Res"},{"issue":"4","key":"1736_CR75","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1471-4159.1968.tb11615.x","volume":"15","author":"L Freysz","year":"1968","unstructured":"Freysz L, Bieth R, Judes C, Sensenbrenner J, Jacob M, Mandel P. [Quantitative distribution of phospholipids in neurons and glial cells isolated from rat cerebral cortex]. J Neurochem. 1968;15(4):307\u201313.","journal-title":"J Neurochem"},{"issue":"1","key":"1736_CR76","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0022-2275(20)39550-X","volume":"12","author":"WT Norton","year":"1971","unstructured":"Norton WT, Poduslo SE. Neuronal perikarya and astroglia of rat brain: chemical composition during myelination. J Lipid Res. 1971;12(1):84\u201390.","journal-title":"J Lipid Res"},{"key":"1736_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7742(08)60649-2","volume":"20","author":"GB Ansell","year":"1977","unstructured":"Ansell GB, Spanner S. Functional metabolism of brain phospholipids. Int Rev Neurobiol. 1977;20:1\u201329.","journal-title":"Int Rev Neurobiol"},{"issue":"10","key":"1736_CR78","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1111\/j.1471-4159.1971.tb09587.x","volume":"18","author":"A Hamberger","year":"1971","unstructured":"Hamberger A, Svennerholm L. Composition of gangliosides and phospholipids of neuronal and glial cell enriched fractions. J Neurochem. 1971;18(10):1821\u20139.","journal-title":"J Neurochem"},{"key":"1736_CR79","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.ircmb.2015.10.001","volume":"321","author":"E Calzada","year":"2016","unstructured":"Calzada E, Onguka O, Claypool SM. Phosphatidylethanolamine Metabolism in Health and Disease. Int Rev Cell Mol Biol. 2016;321:29\u201388.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"7","key":"1736_CR80","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1023\/A:1011603916962","volume":"26","author":"JW Pettegrew","year":"2001","unstructured":"Pettegrew JW, Panchalingam K, Hamilton RL, McClure RJ. Brain membrane phospholipid alterations in Alzheimer\u2019s disease. Neurochem Res. 2001;26(7):771\u201382.","journal-title":"Neurochem Res"},{"issue":"1","key":"1736_CR81","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/A:1022457605436","volume":"23","author":"MR Prasad","year":"1998","unstructured":"Prasad MR, Lovell MA, Yatin M, Dhillon H, Markesbery WR. Regional membrane phospholipid alterations in Alzheimer\u2019s disease. Neurochem Res. 1998;23(1):81\u20138.","journal-title":"Neurochem Res"},{"key":"1736_CR82","doi-asserted-by":"crossref","unstructured":"Vasquez J, Roldan E. Phospholipid metabolism in boar spermatozoa and role of diacylglycerol species in the De Novo formation of phosphatidylcholine. Mol Reprod Dev. 1997;47.","DOI":"10.1002\/(SICI)1098-2795(199705)47:1<105::AID-MRD14>3.3.CO;2-G"},{"issue":"3","key":"1736_CR83","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.plipres.2011.02.004","volume":"50","author":"M Hermansson","year":"2011","unstructured":"Hermansson M, Hokynar K, Somerharju P. Mechanisms of glycerophospholipid homeostasis in mammalian cells. Prog Lipid Res. 2011;50(3):240\u201357.","journal-title":"Prog Lipid Res"},{"issue":"3","key":"1736_CR84","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1194\/jlr.C600019-JLR200","volume":"48","author":"Y Horibata","year":"2007","unstructured":"Horibata Y, Hirabayashi Y. Identification and characterization of human ethanolaminephosphotransferase1. J Lipid Res. 2007;48(3):503\u20138.","journal-title":"J Lipid Res"},{"issue":"2","key":"1736_CR85","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrm2330","volume":"9","author":"G van Meer","year":"2008","unstructured":"van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008;9(2):112\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"1736_CR86","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1111\/bph.12283","volume":"171","author":"C Rodriguez-Cueto","year":"2014","unstructured":"Rodriguez-Cueto C, Benito C, Fernandez-Ruiz J, Romero J, Hernandez-Galvez M, Gomez-Ruiz M. Changes in CB(1) and CB(2) receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias. Br J Pharmacol. 2014;171(6):1472\u201389.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"1736_CR87","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41593-021-00818-4","volume":"24","author":"EMM Carlsen","year":"2021","unstructured":"Carlsen EMM, Falk S, Skupio U, Robin L, Pagano Zottola AC, Marsicano G, et al. Spinal astroglial cannabinoid receptors control pathological tremor. Nat Neurosci. 2021;24(5):658\u201366.","journal-title":"Nat Neurosci"},{"issue":"4819","key":"1736_CR88","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1126\/science.2820055","volume":"237","author":"B Samuelsson","year":"1987","unstructured":"Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 1987;237(4819):1171\u20136.","journal-title":"Science"},{"key":"1736_CR89","doi-asserted-by":"publisher","first-page":"101359","DOI":"10.1016\/j.arr.2021.101359","volume":"69","author":"M Yan","year":"2021","unstructured":"Yan M, Zhang S, Li C, Liu Y, Zhao J, Wang Y, et al. 5-Lipoxygenase as an emerging target against age-related brain disorders. Ageing Res Rev. 2021;69:101359.","journal-title":"Ageing Res Rev"},{"key":"1736_CR90","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbi.2021.12.004","volume":"100","author":"MC Barbosa-Silva","year":"2022","unstructured":"Barbosa-Silva MC, RM PC, Del Castilo I, Franca JV, Frost PS, Penido C, et al. Mice lacking 5-lipoxygenase display motor deficits associated with cortical and hippocampal synapse abnormalities. Brain Behav Immun. 2022;100:183\u201393.","journal-title":"Brain Behav Immun"},{"issue":"3\u20134","key":"1736_CR91","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/BF01986575","volume":"33","author":"L Iversen","year":"1991","unstructured":"Iversen L, Fogh K, Bojesen G, Kragballe K. Linoleic acid and dihomogammalinolenic acid inhibit leukotriene B4 formation and stimulate the formation of their 15-lipoxygenase products by human neutrophils in vitro. Evidence of formation of antiinflammatory compounds. Agents Actions. 1991;33(3\u20134):286\u201391.","journal-title":"Agents Actions"},{"key":"1736_CR92","doi-asserted-by":"crossref","unstructured":"Rajan S, Jang Y, Kim CH, Kim W, Toh HT, Jeon J et al. PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function. Nat Chem Biol. 2020.","DOI":"10.1038\/s41589-020-0553-6"},{"issue":"1","key":"1736_CR93","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2174\/157015910790909485","volume":"8","author":"AL Bartels","year":"2010","unstructured":"Bartels AL, Leenders KL. Cyclooxygenase and neuroinflammation in Parkinson\u2019s disease neurodegeneration. Curr Neuropharmacol. 2010;8(1):62\u20138.","journal-title":"Curr Neuropharmacol"},{"issue":"9","key":"1736_CR94","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","volume":"63","author":"L Minghetti","year":"2004","unstructured":"Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol. 2004;63(9):901\u201310.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5548","key":"1736_CR95","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","volume":"294","author":"CD Funk","year":"2001","unstructured":"Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294(5548):1871\u20135.","journal-title":"Science"},{"issue":"9\u201310","key":"1736_CR96","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","volume":"17","author":"N Fabelo","year":"2011","unstructured":"Fabelo N, Martin V, Santpere G, Marin R, Torrent L, Ferrer I, et al. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson\u2019s disease and incidental Parkinson\u2019s disease. Mol Med. 2011;17(9\u201310):1107\u201318.","journal-title":"Mol Med"},{"issue":"4","key":"1736_CR97","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0306-4522(00)00501-7","volume":"102","author":"BM Ross","year":"2001","unstructured":"Ross BM, Mamalias N, Moszczynska A, Rajput AH, Kish SJ. Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson\u2019s disease. Neuroscience. 2001;102(4):899\u2013904.","journal-title":"Neuroscience"},{"key":"1736_CR98","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev.biophys.093008.131234","volume":"39","author":"PA Leventis","year":"2010","unstructured":"Leventis PA, Grinstein S. The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys. 2010;39:407\u201327.","journal-title":"Annu Rev Biophys"},{"issue":"36","key":"1736_CR99","doi-asserted-by":"publisher","first-page":"31664","DOI":"10.1074\/jbc.M504894200","volume":"280","author":"S Kubo","year":"2005","unstructured":"Kubo S, Nemani VM, Chalkley RJ, Anthony MD, Hattori N, Mizuno Y, et al. A combinatorial code for the interaction of alpha-synuclein with membranes. J Biol Chem. 2005;280(36):31664\u201372.","journal-title":"J Biol Chem"},{"issue":"16","key":"1736_CR100","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson WS, Jonas A, Clayton DF, George JM. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem. 1998;273(16):9443\u20139.","journal-title":"J Biol Chem"},{"issue":"44","key":"1736_CR101","doi-asserted-by":"publisher","first-page":"34393","DOI":"10.1074\/jbc.M004851200","volume":"275","author":"RJ Perrin","year":"2000","unstructured":"Perrin RJ, Woods WS, Clayton DF, George JM. Interaction of human alpha-synuclein and Parkinson\u2019s disease variants with phospholipids. Structural analysis using site-directed mutagenesis. J Biol Chem. 2000;275(44):34393\u20138.","journal-title":"J Biol Chem"},{"issue":"12","key":"1736_CR102","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1212\/01.WNL.0000166038.67153.9F","volume":"64","author":"LM de Lau","year":"2005","unstructured":"de Lau LM, Bornebroek M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology. 2005;64(12):2040\u20135.","journal-title":"Neurology"},{"key":"1736_CR103","doi-asserted-by":"crossref","unstructured":"Kerdiles O, Oye Mintsa Mi-Mba MF, Coulombe K, Tremblay C, \u00c9mond V, et al. Additive neurorestorative effects of exercise and docosahexaenoic acid intake in a mouse model of Parkinson\u2019s disease. Neural Regen Res. 2025;20(2):574\u2013586.","DOI":"10.4103\/NRR.NRR-D-23-00595"},{"key":"1736_CR104","doi-asserted-by":"crossref","unstructured":"Fecchio C, Palazzi L, de Laureto PP. \u03b1-Synuclein and polyunsaturated fatty acids: molecular basis of the Interaction and Implication in Neurodegeneration. Molecules. 2018;23(7).","DOI":"10.3390\/molecules23071531"},{"key":"1736_CR105","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","volume":"6","author":"S Fanning","year":"2020","unstructured":"Fanning S, Selkoe D, Dettmer U. Parkinson\u2019s disease: proteinopathy or lipidopathy? Npj Parkinson\u2019s Disease. 2020;6:3.","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"1","key":"1736_CR106","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s13668-018-0222-5","volume":"7","author":"H Gardener","year":"2018","unstructured":"Gardener H, Caunca MR. Mediterranean Diet in preventing neurodegenerative diseases. Curr Nutr Rep. 2018;7(1):10\u201320.","journal-title":"Curr Nutr Rep"},{"key":"1736_CR107","doi-asserted-by":"crossref","unstructured":"Arevalo-Rodriguez I, Smailagic N, Roqu\u00e9 i Figuls M, Ciapponi A, Sanchez\u2010Perez E, Giannakou A et al. Mini\u2010Mental State Examination (MMSE) for the detection of Alzheimer\u2019s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Reviews. 2015(3).","DOI":"10.1002\/14651858.CD010783.pub2"},{"issue":"6","key":"1736_CR108","doi-asserted-by":"publisher","first-page":"e100519","DOI":"10.1371\/journal.pone.0100519","volume":"9","author":"AN Fonteh","year":"2014","unstructured":"Fonteh AN, Cipolla M, Chiang J, Arakaki X, Harrington MG. Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer\u2019s disease. PLoS ONE. 2014;9(6):e100519.","journal-title":"PLoS ONE"},{"key":"1736_CR109","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1212\/01.WNL.0000154532.98495.BF","volume":"64","author":"M Park","year":"2005","unstructured":"Park M, Ross G, Petrovitch H, White L, Masaki K, Nelson J, et al. Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology. 2005;64:1047\u201351.","journal-title":"Neurology"},{"key":"1736_CR110","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/aje\/kwk089","volume":"165","author":"H Chen","year":"2007","unstructured":"Chen H, O\u2019Reilly E, McCullough M, Rodriguez C, Schwarzschild M, Calle E, et al. Consumption of dairy products and risk of Parkinson\u2019s Disease. Am J Epidemiol. 2007;165:998\u20131006.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1736_CR111","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/1531-8257(199901)14:1<21::AID-MDS1006>3.0.CO;2-Y","volume":"14","author":"C Anderson","year":"1999","unstructured":"Anderson C, Checkoway H, Franklin GM, Beresford S, Smith-Weller T, Swanson PD. Dietary factors in Parkinson\u2019s disease: the role of food groups and specific foods. Mov Disord. 1999;14(1):21\u20137.","journal-title":"Mov Disord"},{"key":"1736_CR112","doi-asserted-by":"publisher","first-page":"6405278","DOI":"10.1155\/2017\/6405278","volume":"2017","author":"LK Mischley","year":"2017","unstructured":"Mischley LK, Lau RC, Bennett RD. Role of Diet and Nutritional supplements in Parkinson\u2019s Disease Progression. Oxid Med Cell Longev. 2017;2017:6405278.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"1736_CR113","first-page":"3810","volume":"20","author":"F Mesa-Herrera","year":"2019","unstructured":"Mesa-Herrera F, Taoro-Gonz\u00e1lez L, Vald\u00e9s-Baizabal C, Diaz M, Mar\u00edn R. Lipid and lipid raft alteration in aging and neurodegenerative diseases: a window for the development of New Biomarkers. Int J Mol Sci. 2019;20(5):3810\u20133819","journal-title":"Z Alternsforsch"},{"issue":"3","key":"1736_CR114","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/BF02531202","volume":"3","author":"G Rouser","year":"1968","unstructured":"Rouser G, Yamamoto A. Curvilinear regression course of human brain lipid composition changes with age. Lipids. 1968;3(3):284\u20137.","journal-title":"Lipids"},{"key":"1736_CR115","first-page":"31","volume-title":"Omega-3 fatty acids in Brain and Neurological Health","author":"M Shichiri","year":"2014","unstructured":"Shichiri M, Yoshida Y, Niki E. Chapter 4 - unregulated lipid peroxidation in neurological dysfunction. In: Watson RR, De Meester F, editors. Omega-3 fatty acids in Brain and Neurological Health. Boston: Academic; 2014. pp. 31\u201355."},{"key":"1736_CR116","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","volume":"13","author":"I Liguori","year":"2018","unstructured":"Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018;13:757\u201372.","journal-title":"Clin Interv Aging"},{"issue":"6","key":"1736_CR117","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1111\/j.1471-4159.1991.tb03466.x","volume":"56","author":"L Svennerholm","year":"1991","unstructured":"Svennerholm L, Bostr\u00f6m K, Helander CG, Jungbjer B. Membrane lipids in the aging human brain. J Neurochem. 1991;56(6):2051\u20139.","journal-title":"J Neurochem"},{"issue":"5","key":"1736_CR118","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1046\/j.1471-4159.1994.63051802.x","volume":"63","author":"L Svennerholm","year":"1994","unstructured":"Svennerholm L, Bostr\u00f6m K, Jungbjer B, Olsson L. Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J Neurochem. 1994;63(5):1802\u201311.","journal-title":"J Neurochem"},{"issue":"1","key":"1736_CR119","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/BF01001351","volume":"3","author":"AA Farooqui","year":"1988","unstructured":"Farooqui AA, Liss L, Horrocks LA. Neurochemical aspects of Alzheimer\u2019s disease: involvement of membrane phospholipids. Metab Brain Dis. 1988;3(1):19\u201335.","journal-title":"Metab Brain Dis"},{"issue":"5","key":"1736_CR120","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.jmb.2007.11.051","volume":"375","author":"M St\u00f6ckl","year":"2008","unstructured":"St\u00f6ckl M, Fischer P, Wanker E, Herrmann A. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains. J Mol Biol. 2008;375(5):1394\u2013404.","journal-title":"J Mol Biol"},{"issue":"27","key":"1736_CR121","doi-asserted-by":"publisher","first-page":"7669","DOI":"10.1007\/s00216-016-9863-7","volume":"408","author":"S Abd-Elhadi","year":"2016","unstructured":"Abd-Elhadi S, Basora M, Vilas D, Tolosa E, Sharon R. Total \u03b1-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA. Anal Bioanal Chem. 2016;408(27):7669\u201377.","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"1736_CR122","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bbapap.2018.10.006","volume":"1867","author":"A Iyer","year":"2019","unstructured":"Iyer A, Claessens MMAE. Disruptive membrane interactions of alpha-synuclein aggregates. Biochim Biophys Acta Proteins Proteom. 2019;1867(5):468\u201382.","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"issue":"11","key":"1736_CR123","doi-asserted-by":"publisher","first-page":"e82732","DOI":"10.1371\/journal.pone.0082732","volume":"8","author":"C Fecchio","year":"2013","unstructured":"Fecchio C, De Franceschi G, Relini A, Greggio E, Dalla Serra M, Bubacco L, et al. \u03b1-Synuclein oligomers induced by docosahexaenoic acid affect membrane integrity. PLoS ONE. 2013;8(11):e82732.","journal-title":"PLoS ONE"},{"issue":"25","key":"1736_CR124","doi-asserted-by":"publisher","first-page":"22262","DOI":"10.1074\/jbc.M110.202937","volume":"286","author":"G De Franceschi","year":"2011","unstructured":"De Franceschi G, Frare E, Pivato M, Relini A, Penco A, Greggio E, et al. Structural and morphological characterization of aggregated species of \u03b1-synuclein induced by docosahexaenoic acid. J Biol Chem. 2011;286(25):22262\u201374.","journal-title":"J Biol Chem"},{"issue":"4","key":"1736_CR125","doi-asserted-by":"publisher","first-page":"292","DOI":"10.5607\/en.2014.23.4.292","volume":"23","author":"D Snead","year":"2014","unstructured":"Snead D, Eliezer D. Alpha-synuclein function and dysfunction on cellular membranes. Exp Neurobiol. 2014;23(4):292\u2013313.","journal-title":"Exp Neurobiol"},{"issue":"17","key":"1736_CR126","doi-asserted-by":"publisher","first-page":"15313","DOI":"10.1074\/jbc.M213128200","volume":"278","author":"S Chandra","year":"2003","unstructured":"Chandra S, Chen X, Rizo J, Jahn R, S\u00fcdhof TC. A broken alpha -helix in folded alpha -synuclein. J Biol Chem. 2003;278(17):15313\u20138.","journal-title":"J Biol Chem"},{"issue":"4","key":"1736_CR127","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","volume":"37","author":"R Sharon","year":"2003","unstructured":"Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, Selkoe DJ. The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease. Neuron. 2003;37(4):583\u201395.","journal-title":"Neuron"},{"key":"1736_CR128","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/1735-1995.181989","volume":"21","author":"FN Emamzadeh","year":"2016","unstructured":"Emamzadeh FN. Alpha-synuclein structure, functions, and interactions. J Res Med Sci. 2016;21:29.","journal-title":"J Res Med Sci"},{"issue":"7","key":"1736_CR129","doi-asserted-by":"publisher","first-page":"e22972","DOI":"10.1096\/fj.202300003R","volume":"37","author":"M Matveyenka","year":"2023","unstructured":"Matveyenka M, Zhaliazka K, Kurouski D. Unsaturated fatty acids uniquely alter aggregation rate of alpha-synuclein and insulin and change the secondary structure and toxicity of amyloid aggregates formed in their presence. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2023;37(7):e22972.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"Pt A","key":"1736_CR130","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.expneurol.2017.12.002","volume":"301","author":"K Coulombe","year":"2018","unstructured":"Coulombe K, Kerdiles O, Tremblay C, Emond V, Lebel M, Boulianne AS, et al. Impact of DHA intake in a mouse model of synucleinopathy. Exp Neurol. 2018;301(Pt A):39\u201349.","journal-title":"Exp Neurol"},{"key":"1736_CR131","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fnagi.2015.00052","volume":"7","author":"SC Dyall","year":"2015","unstructured":"Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci. 2015;7:52.","journal-title":"Front Aging Neurosci"},{"key":"1736_CR132","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnagi.2014.00036","volume":"6","author":"SE Seidl","year":"2014","unstructured":"Seidl SE, Santiago JA, Bilyk H, Potashkin JA. The emerging role of nutrition in Parkinson\u2019s disease. Front Aging Neurosci. 2014;6:36.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"1736_CR133","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s00429-017-1375-5","volume":"222","author":"C Gonzalez-Riano","year":"2017","unstructured":"Gonzalez-Riano C, Tapia-Gonz\u00e1lez S, Garc\u00eda A, Mu\u00f1oz A, DeFelipe J, Barbas C. Metabolomics and neuroanatomical evaluation of post-mortem changes in the hippocampus. Brain Struct Funct. 2017;222(6):2831\u201353.","journal-title":"Brain Struct Funct"},{"issue":"5327","key":"1736_CR134","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/234304a0","volume":"234","author":"RB Zurier","year":"1971","unstructured":"Zurier RB, Quagliata F. Effect of prostaglandin E 1 on adjuvant arthritis. Nature. 1971;234(5327):304\u20135.","journal-title":"Nature"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-024-01736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-024-01736-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-024-01736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T04:21:46Z","timestamp":1732335706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-024-01736-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":134,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1007\/s12311-024-01736-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3982727\/v1","asserted-by":"object"}]},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,31]]},"assertion":[{"value":"21 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human brain samples included in the present study were from patients or a family member who had filled out a consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}